Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
PHYSICIANS FORMULA HOLDINGS, INC. (FACE)
|
|
| Income Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Sep-30-12 | Jun-30-12 | Mar-31-12 | Dec-31-11 | Sep-30-11 | Jun-30-11 | Mar-31-11 | Dec-31-10 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues: |
| United States | 16.8 | 22.8 | 23.3 | | 13.9 | 18.1 | 18.6 | |
| Canada | 1.9 | 2.7 | 2.8 | | 1.8 | 2.6 | 2.4 | |
| Other | 0.4 | 0.7 | 0.1 | | 0.2 | 0.1 | 0.1 | |
| Total revenues | 19.1 | 26.1 | 26.2 | 23.1 | 15.9 | 20.9 | 21.1 | 20.5 |
| Revenue growth [+] | 20.4% | 25.2% | 24.0% | 12.7% | 10.7% | 0.5% | -8.0% | -8.4% |
| United States | 21.5% | 25.6% | 25.0% | | 9.2% | 2.7% | -7.4% | |
| Canada | 4.8% | 4.1% | 17.4% | | 34.7% | -12.0% | -16.5% | |
| Cost of goods sold | 9.5 | 12.3 | 12.8 | 13.1 | 8.0 | 10.8 | 10.9 | 12.6 |
| Gross profit | 9.6 | 13.8 | 13.4 | 10.0 | 7.9 | 10.1 | 10.3 | 7.9 |
| Gross margin | 50.3% | 52.9% | 51.1% | 43.3% | 49.7% | 48.4% | 48.6% | 38.5% |
| Selling, general and administrative | 10.3 | 10.5 | 9.8 | 10.0 | 8.3 | 10.0 | 8.8 | 9.2 |
| EBITDA [+] | 0.5 | 4.5 | 4.8 | 1.2 | 0.9 | 1.3 | 2.6 | -0.2 |
| EBITDA growth | -47.1% | 248.2% | 82.4% | -825.1% | -13.1% | -62.4% | 7.4% | -92.7% |
| EBITDA margin | 2.4% | 17.3% | 18.4% | 5.4% | 5.5% | 6.2% | 12.5% | -0.8% |
| Depreciation | 0.7 | 0.7 | 1.2 | 1.3 | 0.8 | 0.8 | 1.2 | 1.1 |
| EBITA | -0.2 | 3.8 | 3.6 | 0.0 | 0.0 | 0.5 | 1.4 | -1.3 |
| EBITA margin | -1.2% | 14.5% | 13.8% | -0.1% | 0.2% | 2.4% | 6.9% | -6.4% |
| Amortization of intangibles | 0.4 | 0.4 | | | 0.4 | 0.4 | | |
| EBIT [+] | -0.7 | 3.3 | 3.6 | 0.0 | -0.4 | 0.1 | 1.4 | -1.3 |
| EBIT growth | 60.2% | 5388.5% | 149.8% | -99.0% | 254.7% | -97.4% | 7.5% | -60.6% |
| EBIT margin | -3.5% | 12.8% | 13.8% | -0.1% | -2.6% | 0.3% | 6.9% | -6.4% |
| Interest expense | 0.1 | 0.1 | 0.2 | 0.4 | 0.6 | 0.6 | 0.6 | 0.6 |
| Interest expense | 0.1 | 0.1 | 0.2 | 0.4 | 0.6 | 0.6 | 0.6 | 0.6 |
| Other income (expense), net [+] | 0.0 | 0.0 | 0.0 | -1.3 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other non-operating gains/losses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Pre-tax income | -0.8 | 3.2 | 3.5 | -1.6 | -1.1 | -0.6 | 0.9 | -1.9 |
| Income taxes | 0.6 | 1.3 | 1.1 | -0.9 | -0.5 | -0.2 | 0.4 | -1.0 |
| Tax rate | | 39.2% | 30.7% | 52.5% | 49.5% | 42.4% | 47.9% | 51.5% |
| Net income | -1.3 | 2.0 | 2.4 | -0.8 | -0.5 | -0.3 | 0.5 | -0.9 |
| Net margin | -7.0% | 7.5% | 9.3% | -3.4% | -3.4% | -1.6% | 2.1% | -4.4% |
| |
| Basic EPS [+] | ($0.10) | $0.14 | $0.18 | ($0.06) | ($0.04) | ($0.02) | $0.03 | ($0.07) |
| Growth | 147.9% | -691.1% | 434.3% | -13.8% | 27.7% | -124.0% | -13.3% | -63.4% |
| Diluted EPS [+] | ($0.10) | $0.13 | $0.16 | ($0.06) | ($0.04) | ($0.02) | $0.03 | ($0.06) |
| Growth | 147.9% | -643.3% | 439.1% | -8.2% | 27.7% | -125.6% | -17.9% | -65.6% |
| |
| Shares outstanding (basic) [+] | 13.7 | 13.7 | 13.7 | 13.6 | 13.6 | 13.6 | 13.6 | 13.6 |
| Growth | 0.8% | 0.9% | 0.6% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% |
| Shares outstanding (diluted) [+] | 13.7 | 14.9 | 14.8 | 13.6 | 13.6 | 13.6 | 14.8 | 14.5 |
| Growth | 0.8% | 9.8% | -0.3% | -6.1% | 0.1% | -6.1% | 5.6% | 6.6% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|